GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sysmex Corp (OTCPK:SSMXY) » Definitions » YoY Rev. per Sh. Growth

SSMXY (Sysmex) YoY Rev. per Sh. Growth : 15.82% (As of Sep. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Sysmex YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. Sysmex's YoY Rev. per Sh. Growth for the quarter that ended in Sep. 2024 was 15.82%.

Sysmex's Revenue per Share for the three months ended in Sep. 2024 was $1.46.

Sysmex YoY Rev. per Sh. Growth Historical Data

The historical data trend for Sysmex's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sysmex YoY Rev. per Sh. Growth Chart

Sysmex Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
YoY Rev. per Sh. Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.20 -0.07 9.19 0.23 0.53

Sysmex Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
YoY Rev. per Sh. Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.33 2.18 8.48 5.87 15.82

Sysmex YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

Sysmex's YoY Rev. per Sh. Growth for the fiscal year that ended in Mar. 2024 is calculated as:

YoY Rev. per Sh. Growth (A: Mar. 2024 )
=(Revenue per Share (A: Mar. 2024 )-Revenue per Share (A: Mar. 2023 ))/ | Revenue per Share (A: Mar. 2023 ) |
=(4.919-4.893)/ | 4.893 |
=0.53 %

Sysmex's YoY Rev. per Sh. Growth for the quarter that ended in Sep. 2024 is calculated as:

YoY Rev. per Sh. Growth (Q: Sep. 2024 )
=(Revenue per Share (Q: Sep. 2024 )-Revenue per Share (Q: Sep. 2023 )) / | Revenue per Share (Q: Sep. 2023 )) |
=(1.464-1.264)/ | 1.264 |
=15.82 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sysmex YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of Sysmex's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Sysmex Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sysmex Corp (OTCPK:SSMXY) » Definitions » YoY Rev. per Sh. Growth
Comparable Companies
TSE:7747 TSE:7733 TSE:7716 TSE:3360 TSE:7730 TSE:8086 TSE:7817 TSE:7780 TSE:3046 TSE:3593 ISRG XPAR:EL BDX XSWX:ALC TSE:7741 WST OCSE:COLO B RMD TSE:4543 XSWX:STMN
Traded in Other Exchanges
SSMXF:USA 6869:Japan 0YX:Germany 0YX:Germany
Address
1-5-1 Wakinohara-Kaigandori, Chuo-ku, Hyogo Prefecture, Kobe, JPN, 6510073
Website
http://www.sysmex.co.jp
Sysmex Corp manufactures and distributes in vitro diagnostic instruments, reagents, and software. The vast majority of the firm's revenue comes from selling tests for human bodily fluids to hospitals and commercial laboratories. Within this industry, the firm specializes in hematology reagents and instruments. Sysmex also sells in vitro diagnostics for applications like urinalysis and hemostasis and provides support and maintenance services for its systems. Over half of the firm's revenue is generated by sales of reagents and services, which are recurring sources of income. Sysmex primarily sells its products to customers in Japan, Europe, the Middle East, and Africa, and the Americas.

Sysmex Headlines

From GuruFocus

Matthews Japan Fund Comments on Sysmex

By Sydnee Gatewood Sydnee Gatewood • 10-21-2020

Matthews Japan Fund Q4 2014 Commentary

By Vera Yuan Vera Yuan • 02-05-2015

Q1 2020 Sysmex Corp Earnings Call Transcript

By GuruFocus Research • 02-15-2024

Full Year 2019 Sysmex Corp Earnings Presentation Transcript

By GuruFocus Research • 02-15-2024

Q3 2020 Sysmex Corp Earnings Call Transcript

By GuruFocus Research • 02-15-2024

Vanguard Health Care Fund Gains 4 International Stocks in 2nd Quarter

By Sydnee Gatewood Sydnee Gatewood • 08-04-2017

Matthews Japan Fund Comments on Sysmex

By Vera Yuan Vera Yuan • 02-05-2015

Q2 2020 Sysmex Corp Earnings Presentation Transcript

By GuruFocus Research • 02-15-2024